Abstract: Safety, efficacy, and tissue residues of ivermectin, a broad spectrum parasiticide, were determined in Alaskan reindeer (Rangifer tarandus). Reindeer treated at 5 times and 10 times the standard dose of 200 mcg/kg had no detectable physical or behavioral reactions to ivermectin injected subcutaneously in the midcervical area. Ivermectin eliminated essentially 100% of reindeer warble larvae (Hypoderma (Oedemagena) tarandi). Tissue levels of ivermectin in back fat, injection site, muscle, liver, and kidney collected 3, 10, 17, and 24 days post injection were determined. All tissues levels rapidly declined and were approaching low unmeasurable amounts at the end of the 24 day test period. Ivermectin is a safe effective parasiticide that has been used successfully to threat thousands of reindeer in Alaska.
to Alaska. They were imported in 1892 from Siberia for use by the Eskimos. At the present time, reindeer in Alaska number approximately 30.000. Renewed interest in the Alaskan reindeer industry over the past 20 years has resulted in a moderate increase in animals. Concern was expressed by the Reindeer Herders' Association over the impact of warbles {Hypoderma (Oedemagena) tarandi) and nasal bots {Cephenemyia trompe) on the health and productivity of their herds. In Alaska, these parasites cause very severe infestations. Up to 2.000 warble larvae have been counted on the back of one reindeer, and numbers in the range of 500 to 1.000 are common. Herders described finding groups of 35 to 40 reindeer dead in late May with the only visible lesions being massive warble infestations, extreme emaciation, tissue necrosis, and loss of skin from the back. Herders also commented on the smaller size of fawns nursing heavily infested females, and that heavily infested yearlings were noticeably smaller in size than lightly infested cohorts. Reindeer owners complained about difficulties in herding reindeer being harassed by warble and nasal bot flies. The unwanted movement of reindeer from areas of good range to less desir-able beach or windy hillside areas was observed during periods of insect harassment (Dieterich, 1981) .
Safety, efficacy and tissue residues of ivermectin, a broad spectrum parasiticide, were tested to determine the suitability of using the product to control warble and nasal bots in reindeer in Alaskan herds (Chabala, 1980; Campell, 1984; Bowie, 1986 ). This report describes field and laboratory studies carried out to gain ap-proval by the United States Food and Drug Administration (FDA) for use of ivermectin in reindeer. Observations in this report are limited to the effects of ivermectin on warble larvae populations, but ivermectin was also used to concurrently threat reindeer nasal bots and internal parasites. Approval for the use of ivermectin in reindeer used for human consumption was obtained in 1985.
Materials and methods
Experimental protocols were developed for testing safety, efficacy and tissue residues of ivermectin in reindeer that would conform to the days 3,7,11,17,24 and 31 post-injection (PI).
Body weights were taken at the time blood was collected.
Efficacy
The efficacy of ivermectin against the reindeer warble was tested in two trials. The first was a pilot study using Both test groups ranged freely with controls on western Alaska tundra ranges. These groups were mixed with reindeer herds that numbered from 4 to 7 thousand animals. The conditions they experienced were typical for reindeer in Alaska.
Tissue residues
The temporal dynamics of ivermectin tissue residues in reindeer were determined to esta-blish a withdrawal time after treatment which would result in acceptable residue levels. 
Results

Safety
None of the treated reindeer had any detectable physical or behavioral reactions to ivermectin. Control and treated reindeer had blood and body weight measurements that were essentially parallel. Males lost weight because of rut behaviour in both control and treated groups.
One reindeer in each group had elevated white blood cell numbers due to unrelated infections.
The injection sites were non-reactive. Rangifer,2 (10), 1990
Efficacy
collected 3, 10, 17 and 24 days PI (Fig. 1) . Back fat had the highest levels of ivermectin present after injection when compared to the other tissues. All tissue levels rapidly declined and were approaching undetectable levels at the end of the 24 day test period. The time in days for 1/2 of the ivermectin to leave each tissue were:
back fat, 7.1; injection site, 2.9; muscle 4.9; liver 5.8; and kidney, 5.7.
Discussion
No (Campbell and Benz, 1984) .
Ivermectin is highly effective in controlling warble infestation in reindeer (Nordkvist et aL, 1984) . The standard dose of the drug eliminates essentially 100% of the warble larvae (Nordkvist, et aL, 1983 ). In the current efficacy trials, there were a few animals treated that had warble larvae present. These animals may not have received the complete dose because cold temperatures and dense hair coats at the time of treatment made accurate administration difficult.
Ivermectin effectively removes many species of parasites in domestic animals. Although effective anthelminthic spectrum of ivermectin in reindeer was not monitored in this study, samples collected from reindeer for clinical diagnostic purposes suggests that ivermectin has the same general effectiveness on reindeer parasites as it has on cattle parasites. Ivermectin has been found to be very effective as a parasiticide in other cervidae as well (Bowie, 1986) .
Post-injection tissue residues of ivermectin decreased rapidly during the 24 days of the study. Back fat residues were initially nearly twice as high as residues in liver, injection site, muscle, or kidney tissue. However, residues in all tissues tested approached zero by day 24. Based on these data, the FDA established a 56 day withholding period. Therefore, in the USA, reindeer injected with ivermectin must not be slaughtered and used for human consumption within 56 days of treatment.
In cattle and sheep, liver is the tissue in which the drug is most persistent while in reindeer, the drug persists longer in fat. The time for 1/2 of the ivermectin to leave cattle liver was 4.9 days compared to 7.1 days to leave reindeer fat at the same dosage rate (Tway et aL, 1981) .
Subjective evidence is available on the overall benefits of using ivermectin in Alaskan reindeer. Herders and researchers have observed larger yearlings, fawns and adults after ivermectin administration. Less insect harassment the summer following treatment has been reported by herders. Ivermectin is a safe effective parasiticide that has been and will continue to be a benefit to the reindeer industry.
